A detailed history of Swisspartners Ltd. transactions in Biovie Inc. stock. As of the latest transaction made, Swisspartners Ltd. holds 294,346 shares of BIVI stock, worth $609,296. This represents 2.92% of its overall portfolio holdings.

Number of Shares
294,346
Previous 161,000 82.82%
Holding current value
$609,296
Previous $401,000 470.32%
% of portfolio
2.92%
Previous 0.41%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$3.86 - $42.0 $514,715 - $5.6 Million
133,346 Added 82.82%
294,346 $2.29 Million
Q2 2022

Aug 10, 2022

BUY
$1.44 - $5.04 $115,889 - $405,614
80,479 Added 99.95%
161,000 $241,000
Q1 2022

May 11, 2022

BUY
$2.74 - $5.65 $192,221 - $396,370
70,154 Added 676.7%
80,521 $380,000
Q1 2022

May 04, 2022

SELL
$2.74 - $5.65 $192,221 - $396,370
-70,154 Reduced 87.13%
10,367 $1.87 Million
Q3 2021

Nov 16, 2021

BUY
$6.69 - $16.93 $167,250 - $423,250
25,000 Added 45.03%
80,521 $542,000
Q2 2021

Aug 11, 2021

BUY
$10.57 - $21.61 $12,905 - $26,385
1,221 Added 2.25%
55,521 $941,000
Q1 2021

May 12, 2021

SELL
$14.35 - $44.81 $297,045 - $927,567
-20,700 Reduced 27.6%
54,300 $1.05 Million
Q4 2020

Feb 12, 2021

BUY
$7.85 - $17.32 $588,750 - $1.3 Million
75,000 New
75,000 $1.3 Million

Others Institutions Holding BIVI

About BIOVIE INC.


  • Ticker BIVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,165,300
  • Market Cap $62.4M
  • Description
  • BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...
More about BIVI
Track This Portfolio

Track Swisspartners Ltd. Portfolio

Follow Swisspartners Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swisspartners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Swisspartners Ltd. with notifications on news.